В большинстве случаев во всем мире считается, что если тромбоциты даж истинно более 50 при хр. иммунной тромбоцитопении, то лечение не нужно, более того, если они падают ниже 50 и нет синяковости/высыпаний, то тоже выжидательная тактика, попробуйте прочитать/понять сей фрагмент:
When the patient remains thrombocytopenic for greater than 6 months, despite therapy, it is both discouraging and frustrating for the patient, family and healthcare team. If the platelet count remains in a hemostatically “safe” range (> 20,000/mm3), patients are often observed without intervention, as these patients continue to show spontaneous remission rates of ~50%/year. Treatment is reserved for clear signs of bleeding: increased bruising, menorrhagia, or prolonged epistaxis.
However, older children wishing to participate in sports requiring a higher platelet count may opt for treatment based on quality of life issues and a desire to enter fully into school activities. For many years, the gold standard therapies used in acute ITP (IVIG, anti-D immunoglobulin, and corticosteroids) were administered as needed to chronic ITP patients, in combination with vincristine or danazol, or on a monthly basis to maintain platelet counts > 50,000/mm3.
отсюда Immune Thrombocytopenic Purpura of Childhood
[Ссылки доступны только зарегистрированным пользователям ]
|